PITTSBURGH, Jan. 29 (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Po…
Biopharmaceuticals, Generics, FDA
Mylan, Polyethylene Glycol 3350, Braintree Laboratories, GoLytely

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Mylan Receives Approval for Generic Version of GoLytely(R)”
Leave a Comment